News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
Biotech/Pharma - Personnel
CEVEC Pharma Appoints New Management Team 9/22/2014
Access Pharmaceuticals (ACCP) Announces Exclusive Global Plasma Therapeutics License, New Management And New Corporate Name 9/22/2014
Codexis, Inc. (CDXS) Appoints Biotechnology Industry Veteran, Kathleen Glaub, To Board Of Directors 9/22/2014
Celladon Corporation Appoints Scott Garrett Vice President, Commercial Planning 9/22/2014
ChemoCentryx, Inc. (CCXI) Appoints Israel F. Charo, M.D., Ph.D., Senior Vice President Of Research 9/22/2014
Synageva BioPharma (GEVA) Appoints Robert Bazemore As Chief Operating Officer 9/22/2014
Nanobiotix Expands Operations Into The U.S.A. As Part Of Its International Development Strategy 9/22/2014
Provectus Biopharmaceuticals Inc. Appoints Christopher Kaplan To Its Strategic Advisory Board 9/22/2014
Premier Biomedical Announces The Addition Of K. Adam Dubov, Esq. To Scientific Advisory Board 9/22/2014
Domain Therapeutics Appoints Professor Michel Bouvier As Chairman Of The Scientific Advisory Board 9/22/2014
RainDance Technologies Names Fritz Eibel As Senior Vice President Of Strategic Marketing 9/22/2014
Cerebain Biotech Engages Miriam Weber Miller, Industry Veteran, As Corporate Vice President 9/22/2014
Protein Technologies Announces Appointment Of Scientific Products Industry Veteran Nate Cosper, Ph.D. As President & Chief Executive Officer 9/22/2014
Ocera Therapeutics, Inc. (OCRX) Announces Appointment Of Steven P. James To Board 9/19/2014
Celgene (CELG) Appoints Tuomo Pätsi As President Of EMEA And Commits To Continue Delivering Innovative Solutions To Meet Patient Needs Across The Region 9/19/2014
Mary Tanner Appointed To Genticel’s Supervisory Board As Independently-Acting Member 9/19/2014
AmpliPhi Biosciences Corporation (APHB) Announces Departure Of CEO 9/19/2014
Horizon Pharma plc.  (HZNP) Announces Board Of Directors Following Closing Of Acquisition Of Vidara Therapeutics International plc 9/19/2014
Merck KGaA (MKGAF.PK) Appoints New Deputy Chief As CEO Kley’s Succession Is Pondered 9/18/2014
Nurix Names Arthur T. Sands, M.D., Ph.D., Chief Executive Officer 9/18/2014
Agilent Technologies Inc. (A) Announces CEO Transition: Mike Mcmullen To Succeed Bill Sullivan In March 2015 9/18/2014
Five Prime Therapeutics, Inc. (FPRX) Appoints Dr. Robert Sikorski As Vice President Of Global Clinical Development 9/18/2014
Corium International, Inc. Announces Appointment Of Paul Goddard, Ph.D. To Board Of Directors 9/18/2014
PDL BioPharma, Inc. (PDLI) Issues Statement On Resignation Of Ernst & Young LLP As Corporate Auditors 9/18/2014
Relmada Therapeutics Appoints Christopher W. James As Senior Director Of Clinical Development 9/18/2014
NOXXON Pharma AG Expands Management Team By Appointing Don Munoz As Chief Financial Officer 9/18/2014
Nexvet Appoints Ashraf Hanna And Joseph Mccracken To Board Of Directors 9/18/2014
Frances K. Heller Rejoins Zafgen (ZFGN) Board Of Directors 9/18/2014
Merck KGaA (MKGAF.PK) Strengthens Executive Board 9/18/2014
BioForward (WI) Announces New Leadership 9/18/2014
Trevena, Inc. (TRVN) Appoints Adam M. Koppel To The Board Of Directors 9/18/2014
NovaBay Pharmaceuticals, Inc. (NBY) Creates Optometry Advisory Board 9/18/2014
OvaScience (OVAS) Appoints Jeffrey Young To Chief Financial Officer 9/18/2014
Agilent Technologies Inc. (A) Creates New Group For Services And Consumables 9/18/2014
Retrophin, Inc. (RTRX) Announces Changes To Board Of Directors And Management Team 9/17/2014
OncoSec Medical Inc. Expands Legal Team, Appoints Sheela Mohan-Peterson As General Counsel And Corporate Secretary 9/17/2014
Alexion Pharmaceuticals Inc. (ALXN) Strengthens and Broadens Its Executive Leadership Team 9/17/2014
BASi (BASI) Names Connie Dougherty Vice President Business Development 9/17/2014
Marina Biotech, Inc. (MRNA) Announces The Election Of Donald A. Williams To Its Board Of Directors 9/17/2014
IXICO plc Release: Appointment Of Chief Financial Officer 9/17/2014
Axsome Therapeutics Announces Appointments To Its Board Of Directors 9/17/2014
Corium International, Inc. Announces Appointment Of Paul Goddard, Ph.D. To Board Of Directors 9/17/2014
Nora Therapeutics Names Sandra Shpilberg Vice President, Strategic Marketing & Commercial Planning 9/17/2014
Christy Noland To Lead Urology Advocacy And Communications For Astellas Pharma Inc. (ALPMY) 9/17/2014
Cancer Geneticist, Alberto Bardelli, Ph.D., Joins TrovaGene, Inc.'s Scientific Advisory Board 9/17/2014
Neumedicines Inc. Names David L. Morash President And Chief Strategy Officer 9/17/2014
Dimension Therapeutics Appoints New CEO, Dr. Annalisa Jenkins 9/16/2014
SAGE Therapeutics Appoints Michael F. Cola To The Company's Board Of Directors 9/16/2014
Dicerna Pharmaceuticals (DRNA) Announces Appointment Of Biotech Industry Leader Bruce Peacock To Its Board Of Directors And Audit Committee 9/16/2014
OncoSec Medical Inc. Appoints Dr. Mai H. Le To Position Of Chief Medical Officer And Names Dr. Robert H. Pierce As Chief Scientific Officer 9/16/2014
FORMA Therapeutics, Inc. Appoints Mary Wadlinger, Senior Vice President, Human Resources, To Executive Leadership Team 9/16/2014
Thermo Fisher Scientific (TMO) Appoints New Members To Scientific Advisory Board 9/16/2014
Dr. Mark Roskey Joins Quanterix Leadership Team 9/16/2014
AMAG Pharmaceuticals, Inc. (AMAG) Appoints Judith Johnson, M.D. As Vice President Of Pharmacovigilance And Pharmacoepidemiology 9/16/2014
Innate Pharma (IPH.PA ) Appoints Pierre Dodion As Chief Medical Officer And Member Of The Executive Committee 9/16/2014
Ex-AVEO Oncology (AVEO) Executive Takes COO Job At Biotech Startup Scholar Rock 9/15/2014
Akebia Therapeutics, Inc. (AKBA) Appoints Ronald C. Renaud Jr. To Its Board Of Directors 9/15/2014
Array BioPharma, Inc. (ARRY) Appoints Victor Sandor, M.D., As Chief Medical Officer 9/15/2014
Sotera Wireless Names Charlie Alvarez To Lead Sales And Marketing 9/15/2014
Purdue Pharma L.P. Names Susie Robinson Vice President of Human Resources 9/15/2014
Antares Pharma, Inc. (ATRS) Announces Promotion Of Robert F. Apple To Chief Operating Officer 9/15/2014
Alnylam Pharmaceuticals (ALNY) Strengthens Management Team With New Key Appointments 9/15/2014
Enumeral Biomedical (ENUM) Appoints Kevin Sarney, CPA, As Vice President Of Finance And Chief Accounting Officer 9/15/2014
ImmunoGen, Inc. (IMGN) Hires Sandra E. Poole As Senior Vice President Of Technical Operations 9/15/2014
Mirna Therapeutics, Inc. Appoints Lawrence M. Alleva To Its Board Of Directors 9/15/2014
Nexvet Expands Australian Veterinary Biologics Research Centre 9/15/2014
Epizyme (EPZM) Appoints Peter Ho, M.D., Ph.D., As Chief Development Officer And Michael Shih, J.D., As Vice President, Business Development 9/15/2014
Array BioPharma, Inc. (ARRY) Appoints Victor Sandor, M.D., As Chief Medical Officer 9/12/2014
Epic Sciences Appoints Glen Freiberg As Vice President Of Regulatory Affairs And Quality Assurance 9/12/2014
Scientific Founder Of Intercept Pharmaceuticals (ICPT) Joins Tiziana Life Sciences Plc 9/12/2014
ExThera Medical Appoints John W. Feik To Its Board Of Directors 9/12/2014
Anacor Pharmaceuticals, Inc. (ANAC) Appoints Wendell Wierenga To Its Board Of Directors 9/12/2014
TSRL, Inc. Announces Appointment Of President 9/12/2014
pSivida Corp (PSDV) Names James Barry To Board Of Directors 9/11/2014
Renowned USC/Norris Cancer Researcher, Dr. Heinz-Josef Lenz, Joins Panther Biotechnology Board Of Directors 9/11/2014
Flamel Technologies (FLML) Announces Plan to Appoint New VP of R&D 9/11/2014
Genocea Biosciences Appoints Kenneth Bate To Its Board of Directors 9/11/2014
Cyclacel Pharmaceuticals, Inc. (CYCC) Appoints Samuel L. Barker, Ph.D. To Board Of Directors 9/11/2014
Agilis Biotherapeutics Names Dr. Mark J. Pykett As President And Chief Executive Officer 9/11/2014
MOCON Announces Retirement Of Vice President & CFO Darrell Lee And Appointment Of Elissa Lindsoe As Successor 9/11/2014
GNS Healthcare Appoints Dr. Jan Berger To Its Board Of Directors 9/11/2014
Afferent Pharmaceuticals Names Kathleen Sereda Glaub As Chief Executive Officer 9/10/2014
PHARMALEX GmbH Establishes U.S. Affiliate And Appoints Andrew S. Verderame To Lead U.S. Business Interests 9/10/2014
Louis J. DeGennaro, Ph.D., Named President And Chief Executive Officer Of The Leukemia & Lymphoma Society 9/10/2014
ERT Announces Appointment Of Jim Corrigan As New President And CEO 9/10/2014
Medgenics, Inc. Announces The Appointment Of Scott Applebaum As Chief Legal Officer 9/10/2014
NovImmune SA Appoints Adrian Mills As Chief Business Officer And Member Of The Executive Committee 9/10/2014
MD Anderson Cancer Center Department Chair Richard E. Champlin, M.D. Joins Actinium Pharmaceuticals, Inc. (ATNM.OB)’s Iomab™-B Scientific Advisory Board 9/10/2014
Ipsen Biopharmaceuticals, Inc. Announces Key Medical And Commercial Hires 9/10/2014
Oragenics, Inc. (OGEN) Appoints Key Hires To Drive Lantibiotic Platform Growth And Expansion 9/10/2014
Boston Biomedical Announces Senior Management Appointments 9/10/2014
New Board Member Joins AFFiRiS AG 9/9/2014
J. Craig Venter Institute Hires Nicole DeBerg As Chief Operating Officer 9/9/2014
To-BBB technologies BV Taps A New CEO 9/9/2014
Second Genome Appoints Karim Dabbagh, Ph.D., As Chief Scientific Officer 9/9/2014
Parnell Pharmaceuticals Holdings Appoints US-Based Independent Directors Phyllis Gardner, M.D., And David L. Greenwood To Its Board Of Directors 9/9/2014
Y-Prime Names Richard Gastineau Chief Operating Officer 9/9/2014
Scott Peoples Joins Marrone Bio Innovations As Vice President Of Marketing 9/9/2014
Acucela Inc. Appoints Biotechnology Industry Veteran And Former Pharmaceutical Executive, Brian O’Callaghan, As Its New President And Chief Operating Officer And Interim CFO; Ryo Kubota, MD, Phd, To Remain In His Role As Chairman And CEO 9/9/2014
Abcam plc (ABC.L) Announces Appointment Of New CEO And Board Changes 9/9/2014
Bruno Lucidi New CEO In Karolinska Development AB Oncology Companies 9/8/2014
CryoPort, Inc. Appoints VP Of Strategic Business Development And Accelerates Expansion Of Direct Sales Force 9/8/2014
Vital Therapies, Inc. (VTI) (VTL) Announces Management Addition; Enrollment In VTI-208 Phase 3 Trial Now 75 Percent Complete 9/8/2014
CollPlant Names Dr. Nadav Orr Vice President Research And Development 9/8/2014
AMAG Pharmaceuticals, Inc. (AMAG) Announces Appointment Of John A. Fallon, M.D. To Board Of Directors 9/8/2014
Aptose Biosciences Recruits Stephen B. Howell, M.D. To Act In The Capacity Of Chief Medical Officer 9/8/2014
Imprimis Pharmaceuticals (immy) Appoints Healthcare Leader William H. Nelson To Its Board Of Directors 9/8/2014
RxTrials Announces Hiring Of Yvonne McCracken As VP Of Clinical Operations And Compliance 9/8/2014
Batu Biologics Names Business Development And R&D Expert As Chief Scientific Officer 9/8/2014
Ignyta (RXDX) Appoints Robert Wild, Ph.D., As Chief Scientific Officer And Senior Vice President, Research 9/8/2014
Robert Hoyt Joins GenomeQuest, Inc. Board Of Directors 9/8/2014
Pivotal Therapeutics Inc. Appoints Accomplished Healthcare And Investment Industry Veteran, Prakash Gowd, As Chief Financial Officer 9/8/2014
Cortex Pharmaceuticals, Inc. (COR) Announces Appointment Of Two Directors; Expands Board To Five Members 9/5/2014
Ardelyx Inc. (ARDX) Chief Scientific Officer, Dominique Charmot, Announces Retirement From The Company At Year-End 9/5/2014
Intrexon Corporation Announces The Appointment Of Keith Canada As Vice President, UltraVector® Division 9/5/2014
ChromaDex, Inc. Names Additional Scientific Advisory Board Members 9/5/2014
Pharma And Biotech Industry Veteran Selected Northwest U.S. Vice President & General Manager For Global Life Science Consulting Firm, Maetrics 9/5/2014
In Memoriam: Joseph Rubin (1938-2014) - CytoSorbents, Inc. Co-founder And Board Director 9/5/2014
Andrew Lewis Joins Astella To Lead Communications For Global Medical & Development 9/5/2014
Dr. Tracy Tsuetaki Joins PAREXEL International (PRXL) As Senior Vice President Of Peri/Post-Approval Services And Parexel Consulting 9/5/2014
Tamarisk Technologies Group Announces New Addition To Science Team 9/5/2014
ISPE Announces 2014 - 2015 Board Of Directors Election Results 9/5/2014
Catalyst Pharmaceutical Partners, Inc. (CPRX) Appoints David D. Muth As Executive Vice President, Corporate Development 9/4/2014
Chimerix, Inc. (CMRX) Appoints W. Garrett Nichols, MD, MS As Chief Medical Officer 9/4/2014
Emergent Health Corp. (EMGE) Announces New Management And Corporate Direction 9/4/2014
Ex-Genentech (RHHBY) Boss Resigns From Roche (RHHBY)'s Board; Fears Conflict Of Interest With New CEO Post At Google Inc.'s Calico 9/4/2014
Voyager Pharmaceutical Corporation Taps Ex-Eli Lilly and Company (LLY) Exec For CEO Post 9/3/2014
Nabriva Therapeutics Appoints Dr. Colin Broom As CEO 9/3/2014
Celator Pharmaceuticals, Inc. Announces Appointment Of Michael Dougherty As Chairman Of The Board 9/3/2014
BIND Therapeutics (BIND) Appoints Two New Board Members 9/3/2014
ProNAi Therapeutics, Inc. Names New President And Chief Executive Officer 9/3/2014
ISA Pharmaceuticals Appoints Hendrik-Jan Laseur As Member Of The Supervisory Board 9/3/2014
ICON Appoints Dr. Ira Spector As Executive Vice President, Analytics And Consulting 9/3/2014
Specialty Vaccine Company PaxVax, Inc. Appoints Mark Meltz Executive Vice President And Chief Legal Officer 9/3/2014
Cerenis Therapeutics, Inc. Appoints Dr. Richard C. Pasternak As Chairman 9/3/2014
Xencor Appoints Debra Zack, M.D., Ph.D., Vice President, Clinical Development And Lloyd Rowland, Senior Vice President, Chief Compliance Officer and General Counsel 9/3/2014
Kiadis Pharma Appoints Jeroen Rovers As Its Chief Medical Officer 9/3/2014
RuiYi (formerly Anaphore) Appoints Mark Saad Chief Financial Officer 9/3/2014
Intensity Therapeutics, Inc. Appoints Ian B. Walters M.D., MBA as Vice President And Chief Medical Officer 9/3/2014
Ironwood Pharmaceuticals (IRWD) Appoints Two New Senior Executives To Support Continued Growth As A Leader In Gastroenterology 9/3/2014
Epizyme (EPZM) Announces Resignation Of President And Chief Financial Officer Jason Rhodes 9/3/2014
LABS Inc. Names Todd G. Johnson As President And Chief Executive Officer 9/3/2014
Dr. Thomas A. Medsger Jr. Joins iBio, Inc. (IBIO) Clinical Advisory Board 9/3/2014
TiGenix Appoints Chief Medical Officer And Vice President Medical Affairs And New Product Commercialisation 9/2/2014
Louis Culot Appointed As BioData Inc.'s CEO 9/2/2014
Aldeyra Therapeutics (ALDX) Expands Drug Development Team In Advance Of NS2 Clinical Trials 9/2/2014
Tokai Pharmaceuticals Appoints Lee Kalowski As Chief Financial Officer 9/2/2014
Distinguished Scientists Join Advanced Cell Technology’s New Scientific Advisory Board 9/2/2014
Mast Therapeutics (MSTX) Announces Management Change 9/2/2014
Sierk Pötting To Be The New CFO (Chief Financial Officer) Of BioNTech Group 9/2/2014
Abaxis, Inc. (ABAX) To Present At CL King's 12th Annual Best Ideas Conference 2014 9/2/2014
EMD Group (EMD Serono, Inc. (Rockland)) Appoints Drew Young To Senior Vice President, Neurology And Immunology 9/2/2014
Cellceutix (CTIX) Appoints Dr. Barry Schechter To Board Of Directors As Company Focuses On Meeting Requirements For Stock Exchange Uplisting 9/2/2014
Shareholders Revolt Over GlaxoSmithKline (GSK)'s Plans To Shake Up Board; Investors Call For Speedy Departure Of Chairman Gent 9/2/2014
Amarantus BioSciences, Inc. Appoints Iain Ross To Board Of Directors 8/29/2014
Isogenica Limited Brings In A New CEO 8/28/2014
Moberg Pharma AB (Formerly known as Moberg Derma)’s Head Of U.S. Operations To Resign By End Of January 2015 8/28/2014
NovaBay Pharmaceuticals, Inc. (NBY) Adds Five Top Ophthalmologists To Its Ophthalmic Advisory Board 8/28/2014
Biogen Idec, Inc. (Massachusetts) (BIIB) Poaches Renowned Neurologist From Novartis AG (NVS) To Lead ALS Innovation Hub 8/27/2014
Appointment Announcement - Dr. Jeremy B. Desai, President and CEO, Apotex Inc. 8/27/2014
Mary Kay Deck Joins Intelomed As Vice President Of Clinical Affairs 8/27/2014
Durata Therapeutics, Inc.  (DRTX) Names Wendy Yarno And J. Martin Carroll To Its Board Of Directors 8/27/2014
Tokai Pharmaceuticals Appoints Daniel T. Dransfield, Ph.D. As Vice President, Head Of Translational Medicine 8/27/2014
BeiGene Co.,Ltd Expands Management Team With Two Strategic Senior Positions 8/27/2014
Nordic Nanovector: The Board Appoints Mr. Luigi Costa As New CEO 8/26/2014
David Borasky Has Been Appointed Vice President Of Quality Management For The Copernicus Group IRB 8/26/2014
Novira Therapeutics Announces Appointment Of Roger J. Pomerantz, M.D., F.A.C.P., As Chair Of Scientific Advisory Board 8/26/2014
Tocagen Inc. Expands Clinical Development Team 8/26/2014
Miriam Monge To Join Sartorius Stedim Biotech As Director Of Marketing For Integrated Solutions 8/26/2014
Lycera Appoints Harinder Singh, Ph.D., As Chair Of Scientific Advisory Board 8/26/2014
Charles Walker Appointed Imugene Limited (IMU.AX) CEO 8/26/2014
Adamis Pharmaceuticals (ADMP) Announces Appointment Of New Members To Its Board Of Directors 8/26/2014
Panther Biotechnology Announces The Appointment Of Two Directors And Securing An Option On A Potential Blockbuster Novel Oncology Small Molecule With Northwestern University That Panther Will Fast Track Into The Clinic 8/26/2014
StemCutis Attracts Stem Cell Entrepreneur For Top Post 8/26/2014
Pharmaceutical Executive Joins Mesoblast Limited (MSB.AX) As Chief Financial Officer 8/25/2014
Thesan Pharmaceuticals Appoints Dr. Bhaskar Chaudhuri To The Board Of Directors August 2014 8/25/2014
Compugen Ltd. (CGEN) Appoints Mr. Ari Krashin As Chief Financial Officer 8/25/2014
Heron Therapeutics, Inc. (APPA) Appoints Esmé C. Smith As Vice President, General Counsel And Secretary 8/25/2014
NC COIN Promotes Karen Shank To Business Development Director 8/25/2014
LanzaTech Announces Appointment Of Chief Financial Officer 8/25/2014
Acesion Pharma Appoints Ingelise Saunders As New Chairman Of The Board 8/25/2014
Bench International Inc. Appoints Dr. Sally Barennes As Vice President, Executive Recruitment 8/25/2014
AxoGen, Inc. (AXGN) Announces Changes To Board Of Directors 8/25/2014
Landauer (LDR) Announces Executive Management Change 8/22/2014
Mallinckrodt Announces Key Leadership Appointments Following Completion Of Questcor Acquisition 8/22/2014
Galena Biopharma  (GALE) CEO Allegedly Fired Following Stock-Promotions Scandal, New CEO Named 8/22/2014
Premune Names Carl K. Johnson Chief Medical Officer 8/21/2014
Lion Biotechnologies, Inc. Names Elma Hawkins President And Chief Operating Officer 8/21/2014
Clintrax Global, Inc. Announces Addition To Executive Team 8/21/2014
Asterias Biotherapeutics Appoints Two Independent Directors And Announces Completion Of Series A Common Stock Distribution 8/21/2014
Innovus Pharma Announces Formation Of A Global Clinical Advisory Board To Support The Growth Of Its Product Zestra® 8/21/2014
Biogen Idec, Inc. (Massachusetts) (BIIB) Names Adriana Karaboutis EVP, Technology And Business Solutions 8/21/2014
Allen Institute for Brain Science Welcomes Peter Saggau As Director Of Research Engineering 8/21/2014
Stephen J Smith, Ph.D., Joins The Allen Institute for Brain Science As Senior Investigator 8/21/2014
IntelliCell BioSciences (SVFC) Adds Raymond Hill To Board Of Directors 8/21/2014
More Exits From Ranbaxy Laboratories (RANBAXY.BO)' Top Management Team 8/21/2014
CDH Proton Center Medical Director Named Fellow Of American Society For Radiation Oncology 8/20/2014
Ipsen (IPN.PA) Appoints Cynthia Schwalm As President And CEO Of Ipsen North America 8/20/2014
ELC Group Appoints Dr. Siddharth Chachad As Head Of Global Clinical Development And Medical Affairs 8/20/2014
Cannabics Pharmaceuticals Recruits Two Former Senior Teva Pharmaceutical Industries Limited (TEVA) Executives To Its Advisory Board 8/20/2014